Article info

Download PDFPDF

Extended report
Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study
  1. Correspondence to Jürgen Braun, Rheumazentrum Ruhrgebiet, Landgrafenstrasse 15, D-44652 Herne, Germany; j.braun{at}rheumazentrum-ruhrgebiet.de
View Full Text

Citation

Braun J, Deodhar A, Inman RD, et al
Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study

Publication history

  • Accepted August 27, 2011
  • First published October 19, 2011.
Online issue publication 
April 04, 2012

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.